Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective (Q38068604)

28 August 2017

1 reference

title

Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective (English)

1 reference

28 August 2017

Klebsiella pneumoniae

0 references

author name string

George L Daikos

1

1 reference

28 August 2017

Antonis Markogiannakis

2

1 reference

28 August 2017

Maria Souli

3

1 reference

28 August 2017

Leonidas S Tzouvelekis

4

1 reference

28 August 2017

1 December 2012

1 reference

Expert Review of Anti-infective Therapy

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

12

1 reference

28 August 2017

1393-1404

1 reference

Major trends in the microbial etiology of nosocomial infection.

28 August 2017

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

A Virulent Nosocomial Klebsiella with a Transferable R Factor for Gentamicin: Emergence and Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

The continuing challenge of ESBLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Plasmid-determined AmpC-type beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenem resistance in Enterobacteriaceae: here is the storm!

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Metallo-beta-lactamases: the quiet before the storm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Crystal Structure of KPC-2: Insights into Carbapenemase Activity in Class A β-Lactamases † , ‡

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 Carbapenemase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Metallo-β-lactamases: a last frontier for β-lactams?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Crystal structure of the OXA-48 beta-lactamase reveals mechanistic diversity among class D carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Spread of OXA-48-encoding plasmid in Turkey and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Comparison of the activity of a human simulated, high-dose, prolonged infusion of meropenem against Klebsiella pneumoniae producing the KPC carbapenemase versus that against Pseudomonas aeruginosa in an in vitro pharmacodynamic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

A case of carbapenemase-producing Klebsiella pneumoniae in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Use of meropenem by continuous infusion to treat a patient with a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Colistin for Klebsiella pneumoniae-associated sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Creeping baselines and adaptive resistance to antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Efficacy and safety of tigecycline: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Excess deaths associated with tigecycline after approval based on noninferiority trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

A review of tigecycline--the first glycylcycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Updated functional classification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo- -lactamase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERI.12.138

21 January 2018

Identifiers

DOI

10.1586/ERI.12.138

1 reference

28 August 2017

1 reference